RSS   Newsletter   Contact   Advertise with us

Cancer Genetics appoints John Jay Roberts as COO

Staff writer | Rutherford, N.J., USA | June 28, 2016
Cancer GeneticsJune 28, 2016, Rutherford, N.J., USA - Cancer Genetics, Inc., a DNA-based cancer diagnostics commpany, announced that John Roberts will join the senior executive team as COO and EVP, finance on July 11, 2016.
Mr. Roberts brings deep operational and financial experience to CGI with a strong track record of disciplined growth, operational excellence, and shareholder value creation in multiple public and private healthcare technology and service companies including InfoLogix, AdvantEdge Healthcare Solutions, Clarient and, most recently, VirMedica.

His professional background includes a deep understanding of clinical and healthcare billing, diagnostics, clinical operations, and healthcare-focused IT.

In addition, Mr. Roberts is a long-standing board member and incoming President-elect of the Drug Information Association (DIA), a neutral, global nonprofit association focused on advancing health care product development around the world by connecting stakeholders to interdisciplinary insights and innovation.

Mr. Roberts has a Master of Business Administration and Bachelor of Science from the University of Maine. He has served as a recognized thought leader and expert panelist for numerous publications and programs related to corporate finance and mergers and acquisitions in the healthcare industry.